133 related articles for article (PubMed ID: 38569430)
1. Extracellular vesicles derived from plasmodium-infected red blood cells alleviate cerebral malaria in plasmodium berghei ANKA-infected C57BL/6J mice.
Lv Y; Wu S; Nie Q; Liu S; Xu W; Chen G; Du Y; Chen J
Int Immunopharmacol; 2024 May; 132():111982. PubMed ID: 38569430
[TBL] [Abstract][Full Text] [Related]
2. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A
Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776
[TBL] [Abstract][Full Text] [Related]
3. A single injection of 19 kda carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(19)) formulated with Montanide ISA and CpG ODN induces protective immune response in mice.
Hirunpetcharat C; Mahakunkijcharoen Y; Jeamwattanalert P; Kittigul L; Mahannop P; Pichyangkul S
Asian Pac J Allergy Immunol; 2011 Sep; 29(3):252-9. PubMed ID: 22053595
[TBL] [Abstract][Full Text] [Related]
4. Neuroimmunological blood brain barrier opening in experimental cerebral malaria.
Nacer A; Movila A; Baer K; Mikolajczak SA; Kappe SH; Frevert U
PLoS Pathog; 2012; 8(10):e1002982. PubMed ID: 23133375
[TBL] [Abstract][Full Text] [Related]
5. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
Keswani T; Bhattacharyya A
Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
[TBL] [Abstract][Full Text] [Related]
6. Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of
Mukherjee S; Ray G; Saha B; Kar SK
Front Immunol; 2021; 12():819469. PubMed ID: 35095923
[TBL] [Abstract][Full Text] [Related]
7. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
Jeamwattanalert P; Mahakunkijcharoen Y; Kittigul L; Mahannop P; Pichyangkul S; Hirunpetcharat C
Clin Vaccine Immunol; 2007 Apr; 14(4):342-7. PubMed ID: 17314232
[TBL] [Abstract][Full Text] [Related]
8. Estradiol, but not dehydroepiandrosterone, decreases parasitemia and increases the incidence of cerebral malaria and the mortality in plasmodium berghei ANKA-infected CBA mice.
Libonati RM; Cunha MG; Souza JM; Santos MV; Oliveira SG; Daniel-Ribeiro CT; Carvalho LJ; do Nascimento JL
Neuroimmunomodulation; 2006; 13(1):28-35. PubMed ID: 16699290
[TBL] [Abstract][Full Text] [Related]
9. [Immune characteristics of
Wang Y; Yao X; Tang MY; Liu L; Song SH; Tao ZY; Xia H; Chang XL; Fang Q
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Nov; 32(6):569-576. PubMed ID: 33325190
[TBL] [Abstract][Full Text] [Related]
10. Parasite densities modulate susceptibility of mice to cerebral malaria during co-infection with Schistosoma japonicum and Plasmodium berghei.
Wang ML; Feng YH; Pang W; Qi ZM; Zhang Y; Guo YJ; Luo EJ; Cao YM
Malar J; 2014 Mar; 13():116. PubMed ID: 24670210
[TBL] [Abstract][Full Text] [Related]
11. Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.
Settles EW; Moser LA; Harris TH; Knoll LJ
Infect Immun; 2014 Mar; 82(3):1343-53. PubMed ID: 24396042
[TBL] [Abstract][Full Text] [Related]
12. CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine.
Kumar S; Jones TR; Oakley MS; Zheng H; Kuppusamy SP; Taye A; Krieg AM; Stowers AW; Kaslow DC; Hoffman SL
Infect Immun; 2004 Feb; 72(2):949-57. PubMed ID: 14742540
[TBL] [Abstract][Full Text] [Related]
13. A blood stage fraction of Plasmodium berghei induces protective and long lasting immune response in BALB/c mice.
Bagai U; Pawar A
Parasitol Int; 2013 Jun; 62(3):329-36. PubMed ID: 23085043
[TBL] [Abstract][Full Text] [Related]
14. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA.
Tamura T; Kimura K; Yuda M; Yui K
Infect Immun; 2011 Oct; 79(10):3947-56. PubMed ID: 21807908
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.
Schmidt KE; Kuepper JM; Schumak B; Alferink J; Hofmann A; Howland SW; Rénia L; Limmer A; Specht S; Hoerauf A
PLoS One; 2018; 13(2):e0192717. PubMed ID: 29438386
[TBL] [Abstract][Full Text] [Related]
16. Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice.
Billman ZP; Kas A; Stone BC; Murphy SC
Malar J; 2016 Apr; 15():238. PubMed ID: 27113469
[TBL] [Abstract][Full Text] [Related]
17. Eosinophils Suppress the Migration of T Cells Into the Brain of
Scheunemann JF; Reichwald JJ; Korir PJ; Kuehlwein JM; Jenster LM; Hammerschmidt-Kamper C; Lewis MD; Klocke K; Borsche M; Schwendt KE; Soun C; Thiebes S; Limmer A; Engel DR; Mueller AK; Hoerauf A; Hübner MP; Schumak B
Front Immunol; 2021; 12():711876. PubMed ID: 34659202
[TBL] [Abstract][Full Text] [Related]
18. Immunization against cerebral pathology in Plasmodium berghei-infected mice.
Curfs JH; Hermsen CC; Meuwissen JH; Eling WM
Parasitology; 1992 Aug; 105 ( Pt 1)():7-14. PubMed ID: 1437278
[TBL] [Abstract][Full Text] [Related]
19. Pre-existing Schistosoma japonicum infection alters the immune response to Plasmodium berghei infection in C57BL/6 mice.
Wang ML; Cao YM; Luo EJ; Zhang Y; Guo YJ
Malar J; 2013 Sep; 12():322. PubMed ID: 24034228
[TBL] [Abstract][Full Text] [Related]
20. Rate of red blood cell destruction varies in different strains of mice infected with Plasmodium berghei-ANKA after chronic exposure.
Helegbe GK; Huy NT; Yanagi T; Shuaibu MN; Yamazaki A; Kikuchi M; Yasunami M; Hirayama K
Malar J; 2009 May; 8():91. PubMed ID: 19416511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]